
No results matched your search
Investing.com – Australia stocks were lower after the close on Thursday, as losses in the Financials, Materials and Metals & Mining sectors led shares lower.
At the close in Sydney, the S&P/ASX 200 lost 0.16%.
The best performers of the session on the S&P/ASX 200 were Healthscope (AX:HSO), which rose 15.27% or 0.310 points to trade at 2.340 at the close. Meanwhile, Sigma Pharmaceuticals Ltd (AX:SIG) added 6.99% or 0.050 points to end at 0.765 and Australian Pharma Industries Ltd (AX:API) was up 6.28% or 0.078 points to 1.312 in late trade.
The worst performers of the session were Boral Ltd. (AX:BLD), which fell 5.23% or 0.360 points to trade at 6.520 at the close. Bank Of Queensland Ltd. (AX:BOQ) declined 4.99% or 0.525 points to end at 9.995 and Mayne Pharma Group Ltd (AX:MYX) was down 4.41% or 0.030 points to 0.650.
Rising stocks outnumbered declining ones on the Sydney Stock Exchange by 685 to 557 and 376 ended unchanged.
Shares in Healthscope (AX:HSO) rose to 52-week highs; rising 15.27% or 0.310 to 2.340. Shares in Bank Of Queensland Ltd. (AX:BOQ) fell to 52-week lows; falling 4.99% or 0.525 to 9.995.
The S&P/ASX 200 VIX, which measures the implied volatility of S&P/ASX 200 options, was up 5.62% to 12.297.
Gold Futures for June delivery was up 0.20% or 2.70 to $1325.50 a troy ounce. Elsewhere in commodities trading, Crude oil for delivery in June rose 0.41% or 0.28 to hit $68.33 a barrel, while the June Brent oil contract rose 0.59% or 0.44 to trade at $74.44 a barrel.
AUD/USD was up 0.11% to 0.7572, while AUD/JPY rose 0.04% to 82.81.
The US Dollar Index Futures was down 0.08% at 90.96.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.